AMBER GOODMAN: Open Payments
NPI 1013305895 · JACKSON, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,481 in 41 payments from 16 companies in 2025. Trend: 2023 $879 · 2024 $809 · 2025 $1,481
Food & beverage: $1,481
| Company | Payments | Amount |
|---|---|---|
| Inspire Medical Systems, Inc. | 3 | $369 |
| Novartis Pharmaceuticals Corporation | 11 | $254 |
| Alnylam Pharmaceuticals Inc. | 3 | $139 |
| AstraZeneca Pharmaceuticals LP | 1 | $119 |
| Shockwave Medical, Inc | 1 | $96 |
| ABBVIE INC. | 4 | $75 |
| Merck Sharp & Dohme LLC | 3 | $65 |
| Kestra Medical Technology Services, Inc. | 3 | $63 |
| Medtronic, Inc. | 1 | $61 |
| PFIZER INC. | 2 | $55 |
Products named: INSPIRE, LEQVIO, AMVUTTRA, LOKELMA, Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter, VERQUVO, Assure WCD, SYMPLICITY G3.
Industry payments across MS — which companies pay providers there.
